跳至主要内容
临床试验/CTRI/2019/04/018765
CTRI/2019/04/018765已完成3 期

“Randomized Controlled Trial Of Kamdhenu Rasa Vati In The Management Of Pandu Roga With Special Reference to Iron Deficiency Anemiaâ€

Self1 个研究点 分布在 1 个国家目标入组 214 人开始时间: 2019年4月24日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
Self
入组人数
214
试验地点
1
主要终点
Randomized Controlled Trial Of Kamdhenu Rasa Vati In The Management Of Pandu Roga With Special Reference to Iron Deficiency Anemia

研究概览

简要总结

Anemia is a major public health problem worldwide and also in India. Iron deficiency anemia (IDA) is one of the leading risk factors for disability and mortality worldwide, affecting both developing and developed countries. Ayurveda offers medicinal preparations which positively treat the basic pathology. Detail description regarding chikitsa tatva in Pandu roga emphasizes ‘Agnivruddhi’ more rather than plain Loha Dhatu vruddhi. This kind of treatment is effective for the long-term curing the root cause of the disease. Hence, the effect continues even after the treatment regimen is stopped. Kamdhenu Rasa vati contains Kajjali, Vatsanabh, Louha bhasma, abhrak bhasma and Trikatu. The ingredients have the property of Agnivruddhi and reduces the symptoms of Pandu Roga. Considering all the above factors, ‘Kamdhenu Rasa Vati’ an Ayurvedic preparation mentioned in Rasayogsagar has been selected as the trial medicine to treat Pandu Roga and study its effects statistically in copmparision with Tab. Ferrous Ascorbate and Folic acid.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • The patients having age between 20 to 50 years irrespective of caste, religion, socio economical status.
  • The patients having symptoms of Pandu roga viz.
  • Panduta (pallor), Hridspandan (palpitations), Akshikut shoth (periorbital edema) 3) Patient with Hb% between 8.00 gm to 10.9 gm 4) Patients of both male and female gender.

排除标准

  • Hemoglobin < 8 gm% in both males and females.
  • Patients suffering from known hematological disorders such as sickle-cell anemia and thalassemia.
  • Patients suffering from known systemic disorders such as hypertension, diabetes mellitus, AIDS, various bleeding disorders, cancer and any other infectious & chronic diseases.
  • Pregnant and lactating females.
  • Patients who have undergone any minor or major surgical procedure in preceding 3 months.
  • Patients who are already being administering any hematinic drugs.

结局指标

主要结局

Randomized Controlled Trial Of Kamdhenu Rasa Vati In The Management Of Pandu Roga With Special Reference to Iron Deficiency Anemia

时间窗: 90 days

次要结局

  • Does Kamdhenu Rasa Vati increase and maintain Hb% for 1 month after withdrawal of the treatment in Pandu Roga (Iron deficiency Anemia)(90 days)

研究者

发起方
Self
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验